Search research articles
Contact Us
Filters
Showing results (101-110 of 263) with videos related to
Page
of 27
Sort By:
Deutsche Medizinische Wochenschrift (1946)
|
March 22, 2003
[Pantoprazole-induced hepatitis]
A Cordes, W Vogt, K P Maier
Scandinavian Journal of Immunology
|
January 1, 1979
Incompatibility between complement components C3 and C5 of guinea-pig and man, an indication of their interaction in C5 activation by classical and alternative C5 convertases
I Von Zabern, R Nolte, W Vogt
Scandinavian Journal of Immunology
|
April 1, 1982
Chain structure of cobra venom factor from Naja naja and Naja haje venom
I von Zabern, H Przyklenk, W Vogt
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 24, 1974
Osmotic and non-osmotic components of the haemolysis induced by the direct lytic factor (DLF) of cobra venom
P G Lankisch, B Damerau, W Vogt
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin
|
January 1, 1988
[Chemotherapeutic possibilities in HIV infection]
M W Vogt, R Lüthy, W Siegenthaler
Immunobiology
|
March 1, 1983
Natural antibodies against a polysaccharide (Bo) from sugar cane mediate its complement-activating effect
X Y Li, R Nolte, W Vogt
Journal of Chromatography
|
May 4, 1984
Improved separation and detection of free porphyrins by high-performance liquid chromatography
H D Meyer, W Vogt, K Jacob
Munchener Medizinische Wochenschrift (1950)
|
January 15, 1971
[Acute renal failure in leptospirosis (with a report on the differential diagnosis of leptospirosis sejrö and leptospirosis icterohaemorrhagica)]
G E Schubert, G Hensel, W Vogt
Monographs in Allergy
|
January 1, 1977
Effects on leukocyte accumulation in vivo of the spasmogenically active (C3a) and inactive (C3ai) cleavage peptides of the third component of complement
B Damerau, H G Höllerhage, W Vogt
Scandinavian Journal of Immunology
|
January 1, 1981
Treatment of human complement components C4 and C3 with amines or chaotropic ions. Evidence of a functional and structural change that provides uncleaved C4 and C3 with properties of their soluble activated froms, C4b and C3b
I von Zabern, R Nolte, W Vogt
Page
of 27
Search research articles
Search
Showing results (101-110 of 263) with videos related to
Sort By:
Page
of 27
Deutsche Medizinische Wochenschrift (1946)
|
March 22, 2003
[Pantoprazole-induced hepatitis]
A Cordes, W Vogt, K P Maier
Scandinavian Journal of Immunology
|
January 1, 1979
Incompatibility between complement components C3 and C5 of guinea-pig and man, an indication of their interaction in C5 activation by classical and alternative C5 convertases
I Von Zabern, R Nolte, W Vogt
Scandinavian Journal of Immunology
|
April 1, 1982
Chain structure of cobra venom factor from Naja naja and Naja haje venom
I von Zabern, H Przyklenk, W Vogt
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 24, 1974
Osmotic and non-osmotic components of the haemolysis induced by the direct lytic factor (DLF) of cobra venom
P G Lankisch, B Damerau, W Vogt
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin
|
January 1, 1988
[Chemotherapeutic possibilities in HIV infection]
M W Vogt, R Lüthy, W Siegenthaler
Immunobiology
|
March 1, 1983
Natural antibodies against a polysaccharide (Bo) from sugar cane mediate its complement-activating effect
X Y Li, R Nolte, W Vogt
Journal of Chromatography
|
May 4, 1984
Improved separation and detection of free porphyrins by high-performance liquid chromatography
H D Meyer, W Vogt, K Jacob
Munchener Medizinische Wochenschrift (1950)
|
January 15, 1971
[Acute renal failure in leptospirosis (with a report on the differential diagnosis of leptospirosis sejrö and leptospirosis icterohaemorrhagica)]
G E Schubert, G Hensel, W Vogt
Monographs in Allergy
|
January 1, 1977
Effects on leukocyte accumulation in vivo of the spasmogenically active (C3a) and inactive (C3ai) cleavage peptides of the third component of complement
B Damerau, H G Höllerhage, W Vogt
Scandinavian Journal of Immunology
|
January 1, 1981
Treatment of human complement components C4 and C3 with amines or chaotropic ions. Evidence of a functional and structural change that provides uncleaved C4 and C3 with properties of their soluble activated froms, C4b and C3b
I von Zabern, R Nolte, W Vogt
Page
of 27